Palmitoylation stabilizes PD-L1 to promote breast tumor growth
Top Cited Papers
- 4 December 2018
- journal article
- letter
- Published by Springer Science and Business Media LLC in Cell Research
- Vol. 29 (1), 83-86
- https://doi.org/10.1038/s41422-018-0124-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Palmitoylation: a protein S-acylation with implications for breast cancernpj Breast Cancer, 2016
- Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activityNature Communications, 2016
- Palmitoylation regulates the intracellular trafficking and stability of c-MetOncotarget, 2016
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinationsScience Translational Medicine, 2016
- Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway SignalingStructure, 2016
- Palmitoylacyltransferase Zdhhc9 inactivation mitigates leukemogenic potential of oncogenic NrasLeukemia, 2015
- MicroRNA-134 activity in somatostatin interneurons regulates H-Ras localization by repressing the palmitoylation enzyme, DHHC9Proceedings of the National Academy of Sciences of the United States of America, 2013
- Covalent lipid modifications of proteinsCurrent Biology, 2013
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerThe New England Journal of Medicine, 2012
- Palmitoylation: policing protein stability and trafficNature Reviews Molecular Cell Biology, 2007